Research programme: non absorbed polymers - Bond Biosciences
Latest Information Update: 28 May 2025
At a glance
- Originator Bond Biosciences
- Class Polymers
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hyperammonaemia; Hypercalcaemia
Most Recent Events
- 28 May 2025 No recent reports of development identified for research development in Hyperammonaemia in USA (PO)
- 28 May 2025 No recent reports of development identified for research development in Hyperammonaemia(Prevention) in USA (PO)
- 28 May 2025 No recent reports of development identified for research development in Hypercalcaemia in USA (PO)